Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saki Nakashima

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cureus|March 29, 2024
Successful Childbirth During Satralizumab Treatment in Neuromyelitis Optica Spectrum DisorderSaki Nakashima, Akihito Hao, Naohiro Uchio, et al.
Chemistry, an Asian Journal|January 1, 2020
Optically Active Helical Lanthanide Complexes: Storable Chiral Lewis Acidic Catalysts for Enantioselective Diels-Alder Reaction of SiloxydienesShinji Harada, Saki Nakashima, Shihori Sekino, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Mapping U.S. POINTER Cognitive-Slope Gains Onto Predicted Clinical Progression: An External-Cohort Translation Analysis With Exploratory Economic ThresholdsSaki Nakashima, Kenichiro Sato, Yoshiki Niimi, et al.
Journal of Alzheimer'S Disease Reports|September 4, 2025
Cost-benefit of dementia insurance for cognitively-unimpaired <i>APOE</i> ε4 homozygotes: A simulation studyKenichiro Sato, Saki Nakashima, Yoshiki Niimi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthSaki Nakashima, Kenichiro Sato, Yoshiki Niimi, et al.
JAR Life|March 21, 2025
Factors affecting participation in web-based Alzheimer's questionnaire surveys: Lessons from the Japanese trial-ready cohortSaki Nakashima, Kenichiro Sato, Yoshiki Niimi, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Study partner profile effects on CDR-SB change in anti-amyloid therapy evaluationAmbre Mounié, Kenichiro Sato, Saki Nakashima, et al.
Rinsho Shinkeigaku = Clinical Neurology|January 21, 2026
[Schwannomatosis diagnosed from an approximately 30-year history of multiple mononeuropathy accompanied by multiple cauda equina nodules: a case report]Haruki Yotsumoto, Atsushi Sudo, Shunsuke Tsutsumi, et al.
Journal of Neuroimmunology|February 11, 2026
Immuno-deficient features of thymoma-associated myasthenia gravis patients with hypogammaglobulinemia: A condition comparable to Good's syndromeSaki Nakashima, Kaori Sakuishi, Manato Hara, et al.
Biotechnology Letters|September 27, 2013
Design of riboregulators for control of cyanobacterial (Synechocystis) protein expressionKoichi Abe, Yuta Sakai, Saki Nakashima, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cureus|March 29, 2024
Successful Childbirth During Satralizumab Treatment in Neuromyelitis Optica Spectrum DisorderSaki Nakashima, Akihito Hao, Naohiro Uchio, et al.
Chemistry, an Asian Journal|January 1, 2020
Optically Active Helical Lanthanide Complexes: Storable Chiral Lewis Acidic Catalysts for Enantioselective Diels-Alder Reaction of SiloxydienesShinji Harada, Saki Nakashima, Shihori Sekino, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Mapping U.S. POINTER Cognitive-Slope Gains Onto Predicted Clinical Progression: An External-Cohort Translation Analysis With Exploratory Economic ThresholdsSaki Nakashima, Kenichiro Sato, Yoshiki Niimi, et al.
Journal of Alzheimer'S Disease Reports|September 4, 2025
Cost-benefit of dementia insurance for cognitively-unimpaired <i>APOE</i> ε4 homozygotes: A simulation studyKenichiro Sato, Saki Nakashima, Yoshiki Niimi, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthSaki Nakashima, Kenichiro Sato, Yoshiki Niimi, et al.
JAR Life|March 21, 2025
Factors affecting participation in web-based Alzheimer's questionnaire surveys: Lessons from the Japanese trial-ready cohortSaki Nakashima, Kenichiro Sato, Yoshiki Niimi, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2026
Study partner profile effects on CDR-SB change in anti-amyloid therapy evaluationAmbre Mounié, Kenichiro Sato, Saki Nakashima, et al.
Rinsho Shinkeigaku = Clinical Neurology|January 21, 2026
[Schwannomatosis diagnosed from an approximately 30-year history of multiple mononeuropathy accompanied by multiple cauda equina nodules: a case report]Haruki Yotsumoto, Atsushi Sudo, Shunsuke Tsutsumi, et al.
Journal of Neuroimmunology|February 11, 2026
Immuno-deficient features of thymoma-associated myasthenia gravis patients with hypogammaglobulinemia: A condition comparable to Good's syndromeSaki Nakashima, Kaori Sakuishi, Manato Hara, et al.
Biotechnology Letters|September 27, 2013
Design of riboregulators for control of cyanobacterial (Synechocystis) protein expressionKoichi Abe, Yuta Sakai, Saki Nakashima, et al.
Pageof 3